Market Cap

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd Market Capitalization:

CN¥2.94 Billion

CNY as of Jan. 1, 2025

US$402.1 Million

business Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd Company Profile

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd Main Stock Listing

SZSE: 300937

Market Capitalization History of Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Pharmaceutical Retailers
Company Market Cap (USD)
Conversion Labs, Inc. $37.07 B
Walgreens Boots Alliance, Inc. $10.15 B
Alibaba Health Information Technology Ltd $6.90 B
Raia Drogasil SA $6.55 B
Matsumotokiyoshi Holdings Co. Ltd $5.61 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $689.42 B
Novo Nordisk $622.07 B
UnitedHealth Group $487.54 B
Johnson & Johnson $353.05 B
AbbVie $301.60 B

Yearly evolution of Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2025 CN¥2.94 B 0.16%
Jan. 1, 2024 CN¥2.93 B 10.26%
Jan. 1, 2023 CN¥2.66 B -20.66%
Jan. 1, 2022 CN¥3.35 B -61.27%
Jan. 1, 2021 CN¥8.65 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd Categories

China languages Healthcare languages Pharmaceutical Retailers
China Healthcare China Pharmaceutical Retailers

Stocks & Indices

Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd has the following listings and related stock indices.


Stock: SZSE: 300937

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.